【Kangpu Biotech Inc.】2026 Q1 EPS -0.07 NTD
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Kangpu Biotech Inc. announced its Q1 2026 financial results, reporting an EPS of -0.07 NTD, with zero revenue and a net loss of 108 million NTD. This indicates a loss-making quarter for the biotechnology company.